Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Abstract Background The prognostic biomarker for patients undergoing curative liver metastasectomy for colorectal cancer (CRC) is lacking. The purpose was to investigate the prognostic role of a lack of CDX2 expression, which has been proposed as a potential biomarker for high-risk relapse in early-...

Full description

Bibliographic Details
Main Authors: Yasuyuki Shigematsu, Kentaro Inamura, Noriko Yamamoto, Yoshihiro Mise, Akio Saiura, Yuichi Ishikawa, Shunji Takahashi, Hiroaki Kanda
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
CDX2
Colorectal cancer
Liver metastasis
Metastasectomy
Chemotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-018-4902-8

Internet

http://link.springer.com/article/10.1186/s12885-018-4902-8

Similar Items